Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist.
Huang Y, Blatt LM, Taylor MW. Huang Y, et al. Among authors: blatt lm. J Interferon Cytokine Res. 1995 Apr;15(4):317-21. doi: 10.1089/jir.1995.15.317. J Interferon Cytokine Res. 1995. PMID: 7627806
Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
Tan H, Derrick J, Hong J, Sanda C, Grosse WM, Edenberg HJ, Taylor M, Seiwert S, Blatt LM. Tan H, et al. Among authors: blatt lm. J Interferon Cytokine Res. 2005 Oct;25(10):632-49. doi: 10.1089/jir.2005.25.632. J Interferon Cytokine Res. 2005. PMID: 16241862
Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T, Blatt LM, Seiwert SD. Wang T, et al. Among authors: blatt lm. J Interferon Cytokine Res. 2006 Jul;26(7):473-83. doi: 10.1089/jir.2006.26.473. J Interferon Cytokine Res. 2006. PMID: 16800786
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
Pianko S, McHutchison JG, Gordon SC, Heaton S, Goodman ZD, Patel K, Cortese CM, Brunt EM, Bacon BR, Blatt LM. Pianko S, et al. Among authors: blatt lm. J Interferon Cytokine Res. 2002 Apr;22(4):483-9. doi: 10.1089/10799900252952271. J Interferon Cytokine Res. 2002. PMID: 12034031 Clinical Trial.
Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
Dhib-Jalbut S, Jiang H, Xia Q, Blatt L, Johnson KP, Hilt D. Dhib-Jalbut S, et al. J Interferon Cytokine Res. 1996 Mar;16(3):195-200. doi: 10.1089/jir.1996.16.195. J Interferon Cytokine Res. 1996. PMID: 8697141
The effects of interferon on the expression of human papillomavirus oncogenes.
Kim KY, Blatt L, Taylor MW. Kim KY, et al. J Gen Virol. 2000 Mar;81(Pt 3):695-700. doi: 10.1099/0022-1317-81-3-695. J Gen Virol. 2000. PMID: 10675406
Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir.
Yi G, Deval J, Fan B, Cai H, Soulard C, Ranjith-Kumar CT, Smith DB, Blatt L, Beigelman L, Kao CC. Yi G, et al. Antimicrob Agents Chemother. 2012 Feb;56(2):830-7. doi: 10.1128/AAC.05438-11. Epub 2011 Dec 5. Antimicrob Agents Chemother. 2012. PMID: 22143520 Free PMC article.
Differential gene induction by type I and type II interferons and their combination.
Sanda C, Weitzel P, Tsukahara T, Schaley J, Edenberg HJ, Stephens MA, McClintick JN, Blatt LM, Li L, Brodsky L, Taylor MW. Sanda C, et al. Among authors: blatt lm. J Interferon Cytokine Res. 2006 Jul;26(7):462-72. doi: 10.1089/jir.2006.26.462. J Interferon Cytokine Res. 2006. PMID: 16800785
Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.
Zhang JF, Hu C, Geng Y, Blatt LM, Taylor MW. Zhang JF, et al. Among authors: blatt lm. Cancer Gene Ther. 1996 Jan-Feb;3(1):31-8. Cancer Gene Ther. 1996. PMID: 8785709
Cell surface binding characteristics correlate with consensus type I interferon enhanced activity.
Klein SB, Blatt LM, Taylor MW. Klein SB, et al. Among authors: blatt lm. J Interferon Cytokine Res. 1996 Jan;16(1):1-6. doi: 10.1089/jir.1996.16.1. J Interferon Cytokine Res. 1996. PMID: 8640445
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback